Effectiveness and Safety of Different Rivaroxaban Dosage Regimens in Patients with Non-Valvular Atrial Fibrillation: A Nationwide, Population-Based Cohort Study

Huang, Hsin-YiHsin-YiHuangSHIN YI LINSHOU-HSIA CHENGCHI-CHUAN WANG2022-04-012022-04-012018-11-012045-2322https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042541038&doi=10.1038%2fs41598-018-21884-y&partnerID=40&md5=9a44b3b60583ac3d2527cc0f98ea570bhttps://scholars.lib.ntu.edu.tw/handle/123456789/603795Effectiveness and Safety of Different Rivaroxaban Dosage Regimens in Patients with Non-Valvular Atrial Fibrillation: A Nationwide, Population-Based Cohort Studyjournal article10.1038/s41598-018-21884-y294726232-s2.0-85042541038